Adial Pharmaceuticals (ADIL) Operating Leases (2021 - 2023)
Adial Pharmaceuticals (ADIL) posted Operating Leases of $135045.0 for Q1 2023, down 10.3% sequentially from $150547.0 in Q4 2022, and down 30.32% YoY from $193797.0 in Q1 2022.
Adial Pharmaceuticals (ADIL) Operating Leases (2021 - 2023) Analysis & Trends
Adial Pharmaceuticals has reported Operating Leases for 3 years, with the latest figure at $135045.0 in Q1 2023.
- Quarterly Operating Leases fell 30.32% year-over-year to $135045.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $135045.0 (down 30.32% YoY) and the FY2022 annual result came in at $150547.0, down 27.4% from the prior year.
- Operating Leases eased to $135045.0 in Q1 2023 per ADIL's latest filing, from $150547.0 in the prior quarter.
- Over five years, Operating Leases peaked at $207375.0 in Q4 2021 and troughed at $135045.0 in Q1 2023.
- A 3-year average of $171959.0 and a median of $172495.0 in 2022 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2023: Operating Leases retreated 27.4% in 2022, then slumped 30.32% in 2023.
- Over 3 years, Operating Leases stood at $207375.0 in 2021, then declined by 27.4% to $150547.0 in 2022, then dropped by 10.3% to $135045.0 in 2023.
- According to Business Quant data, Operating Leases over the past three periods registered $135045.0, $150547.0, and $165288.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Adial Pharmaceuticals | 29.02 Mn | 29.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 135,045.00 |
| Dec 31, 2022 | 150,547.00 |
| Sep 30, 2022 | 165,288.00 |
| Jun 30, 2022 | 179,702.00 |
| Mar 31, 2022 | 193,797.00 |
| Dec 31, 2021 | 207,375.00 |